Isoform-Specific Transcriptomic Effects of miR-133A1, miR-133A2, and miR-133B in a Colorectal Cancer Cell Line

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• MicroRNA-133 (miR-133) is recognized as a tumor suppressor in various cancers.
• The specific roles of miR-133A1, miR-133A2, and miR-133B in colorectal cancer (CRC) are not well understood.

Purpose of the Study:

• To investigate the isoform-specific contributions of miR-133A1, miR-133A2, and miR-133B in colorectal cancer.
• To identify shared and distinct transcriptional programs regulated by each miR-133 isoform.

Main Methods:

• Stable colorectal cancer cell lines expressing individual miR-133 isoforms were created.
• Isoform-level transcriptomic profiling was performed, followed by differential gene expression (DEG) analysis.
• Gene Ontology (GO) and KEGG pathway enrichment analyses were conducted on DEGs.

Main Results:

• All three miR-133 isoforms demonstrated a core regulatory program affecting 34 upregulated and 195 downregulated genes.
• Isoform-specific DEGs were identified, indicating both convergent and divergent transcriptional effects.
• Survival and proliferation gene expression changes were more pronounced with miR-133A2 and miR-133B.

Conclusions:

• miR-133 isoforms in colorectal cancer exhibit both common and subtly different regulatory functions.
• These isoforms coordinate apoptosis, proliferation, migration, and signaling pathways.
• Isoform-specific regulation of miR-133 presents potential biomarkers and therapeutic targets for CRC.